GF Fund Management’s Wave Life Sciences WVE Stock Holding History

GF Fund Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$22.6K	Buy	6,098 +2,113	+53%	+$11.1K	﹤0.01%	477
2026 Q2	$23.2K	Buy	3,985 +231	+6%	+$1.53K	﹤0.01%	470
2026 Q1	$27.2K	Buy	3,754 +469	+14%	+$6.11K	﹤0.01%	467
2025 Q4	$55.8K	Sell	3,285 -139	-4%	-$1.41K	﹤0.01%	398
2025 Q3	$25.1K	Sell	3,424 -481	-12%	-$3.89K	﹤0.01%	463
2025 Q2	$25.4K	Hold	3,905	–	–	﹤0.01%	476
2025 Q1	$31.6K	Buy	3,905 +703	+22%	+$7.69K	﹤0.01%	453
2024 Q4	$39.6K	Buy	+3,202	New	+$42.7K	﹤0.01%	415

Other funds holding WVE

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $36M AUM 11.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

GF Fund Management's WVE Position: Q3 2026 in Review

GF Fund Management increased its Wave Life Sciences (WVE) stake by 53% in Q3 2026, buying an estimated $11.1K and bringing the position to 6,098 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

GF Fund Management first reported a position in WVE in Q4 2024 and has held it in 8 quarters since. The position peaked at $55.8K in Q4 2025. 149 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

GF Fund Management held 6,098 shares of Wave Life Sciences worth $22.6K as of Q3 2026.
GF Fund Management bought 2,113 Wave Life Sciences shares in Q3 2026, an estimated $11.1K.
Wave Life Sciences made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #477 holding.
GF Fund Management first reported a position in Wave Life Sciences in Q4 2024 and has held it in 8 quarters since.
GF Fund Management's Wave Life Sciences position peaked at $55.8K in Q4 2025.
149 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.